retatrutide weight loss clinical trial results just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a phase 2 study: • Up to 24.2% mean at 48 weeks Medscape | Retatrutide, Eli Lilly's

We propose that GLP-1 analogs are superior to DPP-4 inhibitors for managing pasireotide-induced hyperglycemia because GLP-1 analogs, unlike DPP-4 inhibitors, spare pasireotide-induced depletion of endogenous GLP-1 and restore insulin secretion suppressed by pasireotide through GLP-1R-Gs activation, counteracting the SSTRs-Gi axis

In a 2022 blog post, Volkow emphasized the need for a pragmatic approach to addiction treatment, stating, the perfect should not be the enemy of the good. She highlighted that only 13% of individuals with drug use disorders receive any treatment, advocating for reduced substance use, not just complete abstinence

Underlying Health Conditions: Pre-existing conditions, such as a history of pancreatitis or thyroid disorders, may increase the risk of serious side effects

Staying hydrated, consuming fiber-rich foods, and avoiding trigger foods or beverages can help alleviate diarrhea and support gastrointestinal health